Neuroblastoma pp 277-288 | Cite as

Late Effects of Treatment

  • Caroline Laverdière
  • James Gurney
  • Charles A. Sklar
Part of the Pediatric Oncology book series (PEDIATRICO)


Hearing Loss Clin Oncol Total Body Irradiation Ovarian Failure Childhood Cancer Survivor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Acharya S, Sarafoglou K, LaQuaglia M et al. (2003) Thyroid neoplasms after therapeutic radiation for malignancies during childhood or adolescence. Cancer 97:2397–2403CrossRefPubMedGoogle Scholar
  2. Aubier F, Flamant F, Brauner R et al. (1989) Male gonadal function after chemotherapy for solid tumors in childhood. J Clin Oncol 7:304–309PubMedGoogle Scholar
  3. Azizkhan RG, Shaw A, Chandler JG (1985) Surgical complications of neuroblastoma resection. Surgery 97:514–517PubMedGoogle Scholar
  4. Barr RD, Chalmers D, De Pauw S et al. (2000) Health-related quality of life in survivors of Wilms' tumor and advanced neuroblastoma: a cross-sectional study. J Clin Oncol 18:3280–3287PubMedGoogle Scholar
  5. Brodeur GM (2003) Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3:203–216CrossRefPubMedGoogle Scholar
  6. Brodeur GM, Maris JM (2002) Neuroblastoma. In: Pizzo PA, Poplack DG (eds) Principles and practice of pediatric oncology, 4th edn. Lippincott, Williams and Wilkins, Philadelphia, pp 895–937Google Scholar
  7. Byrne J, Fears TR, Gail MH et al. (1992) Early menopause in long-term survivors of cancer during adolescence. Am J Obstet Gynecol 166:788–793PubMedGoogle Scholar
  8. Cheung NKV, Kushner BH, Cheung IY et al. (1998) Anti-GD2 antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age. J Clin Oncol 16:3053–3060PubMedGoogle Scholar
  9. Cheung NKV, Kushner BH, LaQuaglia M et al. (2001) N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age. Med Pediatr Oncol 36:227–230PubMedGoogle Scholar
  10. Constine LS, Donaldson SS, McDougall IR et al. (1984) Thyroid dysfunction after radiotherapy in children with Hodgkin's disease. Cancer 53:878–883PubMedGoogle Scholar
  11. Cronin S, Uberti JP, Ayash LJ et al. (2000) Use of amifostine as a chemoprotectant during high-dose chemotherapy in autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 26:1247–1249CrossRefPubMedGoogle Scholar
  12. Cruccetti A, Kiely EM, Spitz L et al. (2000) Pelvic neuroblastoma: low mortality and high morbidity. J Pediatr Surg 35:724–728CrossRefPubMedGoogle Scholar
  13. De Bernardi B, Pianco C, Pistamiglio P et al. (2001) Neuroblastoma with symptomatic spinal cord compression at diagnosis: treatment and results with 76 cases. J Clin Oncol 19:183–190PubMedGoogle Scholar
  14. De Vathaire F, François P, Hill C et al. (1989) Role of radiotherapy and chemotherapy in the risk of second malignant neoplasms after cancer in childhood. Br J Cancer 59:792–796PubMedGoogle Scholar
  15. Drotar D (ed) Measuring health-related quality of life in children and adolescents: implications for research and practice. Lawrence Erlbaum Associates, Publishers, Mahwah, New JerseyGoogle Scholar
  16. Estilo CL, Huryn JM, Kraus DH et al. (2003) Effects of therapy on dentofacial development in long-term survivors of head and neck rhabdomyosarcoma: the Memorial Sloan-Kettering Cancer Center Experience. J Pediatr Hematol Oncol 25:215–222CrossRefPubMedGoogle Scholar
  17. Fulda S, Fichtner I, Hero B et al. (2001) Preclinical and clinical aspects on the use of amifostine as chemoprotection in neuroblastoma patients. Med Pediatr Oncol 36:199–202PubMedGoogle Scholar
  18. Garaventa A, Guerra P, Arrighini A et al. (1991) Treatment of advanced neuroblastoma with 131I-meta-iodobenzylguanidine. Cancer 67:922–928PubMedGoogle Scholar
  19. Garaventa A, Gambina C, Villavecchia G et al. (2003) Second malignancies in children with neuroblastoma after combined treatment with 131I-metaiodobenzylguanidine. Cancer 97:1332–1338CrossRefPubMedGoogle Scholar
  20. Goren MP (2003) Cisplatin nephrotoxicity affects magnesium and calcium metabolism. Med Pediatr Oncol 41:186–189CrossRefPubMedGoogle Scholar
  21. Gupta M, Steinherz PG, Cheung NK et al. (2003) Late cardiotoxicity after bolus versus infusion anthracycline therapy for childhood cancers. Med Pediatr Oncol 40:343–347CrossRefPubMedGoogle Scholar
  22. Halperin EC, Constine LS, Tarbell NJ (1999) Late effects of cancer treatment. In: Halperin EC, Constine LS, Tarbell NJ, Kun LE (eds) Pediatric radiation oncology, 3rd edn. Lippincott, Williams and Wilkins, Philadelphia, pp 457–537Google Scholar
  23. Hancock SL, Cox RS, McDougall IR (1991) Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med 325:599–605PubMedGoogle Scholar
  24. Hölttä P, Alaluusua S, Saarinen-Pihkala UM et al. (2002) Longterm adverse effects on dentition in children with poor-risk neuroblastoma treated with high-dose chemotherapy and autologous stem cell transplantation with or without total body irradiation. Bone Marrow Transplant 29:121–127CrossRefPubMedGoogle Scholar
  25. Hoover M, Bowman LC, Crawford SE et al. (1999) Long-term outcome of patients with intraspinal neuroblastoma. Med Pediatr Oncol 32:353–359CrossRefPubMedGoogle Scholar
  26. Hovi L, Saarinen-Pihkala UM, Vettenranta K et al. (1999) Growth in children with poor-risk neuroblastoma after regimens with or without total body irradiation in preparation for autologous bone marrow transplantation. Bone Marrow Transplant 24:1131–1136CrossRefPubMedGoogle Scholar
  27. Joyce CRB, O'Boyle CA, McGee H (1999) Individual quality of life: approaches to conceptualisation and assessment. Harwood, The NetherlandsGoogle Scholar
  28. Kajanti M (1983) Neuroblastoma in 88 children: clinical features, prognostic factors, results and late effects of therapy. Ann Clin Res 15(Suppl 39):1–68Google Scholar
  29. Kaplan MM, Garnick MB, Gelber R et al. (1983) Risk factors for thyroid abnormalities after neck irradiation for childhood cancer. Am J Med 74:272–280CrossRefPubMedGoogle Scholar
  30. Kaste SC, Hopking KP, Bowman LC et al. (1998) Dental abnormalities in children treated for neuroblastoma. Med Pediatr Oncol 30:22–27CrossRefPubMedGoogle Scholar
  31. Katzenstein HM, Kent PM, London WB et al. (2001) Treatment and outcome of 83 children with intraspinal neuroblastoma: the Pediatric Oncology Group experience. J Clin Oncol 19:1047–1055PubMedGoogle Scholar
  32. Kelaghan J, Myers MH, Mulvihill JJ et al. (1988) Educational achievement of long-term survivors of childhood and adolescent cancer. Med Pediatr Oncol 16:320–326PubMedGoogle Scholar
  33. Koyle MA, Hatch DA, Furness PD III et al. (2001) Long-term urological complications in survivors younger than 15 months of advanced stage abdominal neuroblastoma. J Urol 166:1455–1458CrossRefPubMedGoogle Scholar
  34. Kramer JH, Crittenden MR, Halberg FE et al. (1992) A prospective study of cognitive functioning following low-dose cranial radiation for bone marrow transplantation. Pediatrics 90:447–450PubMedGoogle Scholar
  35. Kushner BH, LaQuaglia MP, Bonilla MA et al. (1994) Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age. J Clin Oncol 12:2607–2613PubMedGoogle Scholar
  36. Kushner BH, Cheung NKV, LaQuaglia MP et al. (1996a) Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy. J Clin Oncol 14:373–381PubMedGoogle Scholar
  37. Kushner BH, Cheung NK, LaQuaglia MP et al. (1996b) International neuroblastoma staging system stage 1 neuroblastoma: a prospective study and literature review. J Clin Oncol 14:2174–2180PubMedGoogle Scholar
  38. Kushner BH, Cheung NK, Kramer K et al. (1998) Neuroblastoma and treatment-related myelodysplasia/leukemia: the Memorial Sloan-Kettering experience and a literature review. J Clin Oncol 16:3880–3889PubMedGoogle Scholar
  39. Kushner BH, Wolden S, LaQuaglia MP et al. (2001) Hyperfractionated low-dose radiotherapy for high-risk neuroblastoma after intensive chemotherapy and surgery. J Clin Oncol 19:2821–2828PubMedGoogle Scholar
  40. Le Deley MC, Leblanc T, Shamsaldin A et al. (2003) Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: a case-control study by the Société Française d'Oncologie Pédiatrique. J Clin Oncol 21:1074–1081CrossRefPubMedGoogle Scholar
  41. Li FP, Gimbrere K, Gelber RD et al. (1987) Outcome of pregnancy in survivors of Wilms' tumor. J Am Med Assoc 257:216–219CrossRefGoogle Scholar
  42. Lipshultz SE, Colan SD, Gelber RD et al. (1991) Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 324:808–815PubMedGoogle Scholar
  43. Lipshultz SE, Lipsitz SR, Mone SM et al. (1995) Female sex and drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. N Engl J Med 332:1738–1743CrossRefPubMedGoogle Scholar
  44. Loebstein R, Koren G (1998) Ifosfamide-induced nephrotoxicity in children: critical review of predictive risk factors. Pediatrics 101:E8CrossRefGoogle Scholar
  45. Mäkipernaa A, Heino M, Laitinen LA et al. (1989) Lung function following treatment of malignant tumors with surgery, radiotherapy, or cyclophosphamide in childhood: a followup study after 11 to 27 years. Cancer 63:625–630PubMedGoogle Scholar
  46. Matthay KK, Sather HN, Seeger RC et al. (1989) Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy. J Clin Oncol 7:236–244PubMedGoogle Scholar
  47. Matthay KK, Perez C, Seeger RC et al. (1998) Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group Study. J Clin Oncol 16:1256–1264PubMedGoogle Scholar
  48. Matthay KK, Villablanca JG, Seeger RC et al. (1999) Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. N Engl J Med 341:1165–1173CrossRefPubMedGoogle Scholar
  49. Mayfield JK, Riseborough EJ, Jaffe N et al. (1981) Spinal deformity in children treated for neuroblastoma: the effect of radiation and other forms of treatment. J Bone Joint Surg 63:183–193PubMedGoogle Scholar
  50. Meadows AT, D'Angio GJ, Evans AE et al. (1975) Oncogenesis and other late effects of cancer treatment in children. Radiology 114:175–180PubMedGoogle Scholar
  51. Meadows AT, Baum E, Fossati-Bellani F et al. (1985) Second malignant neoplasms in children: an update from the Late Effects Study Group. J Clin Oncol 3:532–538PubMedGoogle Scholar
  52. Mertens AC, Yasui Y, Liu Y et al. (2002) Pulmonary complications in survivors of childhood and adolescent cancer: a report from the Childhood Cancer Survivor Study. Cancer 95:2431–2441CrossRefPubMedGoogle Scholar
  53. Mitby PA, Robison LL, Whitton JA et al. (2003) Utilization of special education services and educational attainment among long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Cancer 97:1115–1126CrossRefPubMedGoogle Scholar
  54. Neglia JP, Friedman DL, Yasui Y et al. (2001) Second malignant neoplasms in five-year survivors of childhood cancer: Childhood Cancer Survivor Study. J Nat Cancer Inst 93:618–629CrossRefPubMedGoogle Scholar
  55. Nenadov Beck M, Meresse V, Hartmann O et al. (1995) Longterm pulmonary sequelae after autologous bone marrow transplantation in children without total body irradiation. Bone Marrow Transplant 16:771–775PubMedGoogle Scholar
  56. Nève V, Foot ABM, Michon J et al. (1999) Longitudinal clinical and functional pulmonary follow-up after megatherapy, fractionated total body irradiation, and autologous bone marrow transplantation for metastatic neuroblastoma. Med Pediatr Oncol 32:170–176CrossRefPubMedGoogle Scholar
  57. Nitschke R, Smith EI, Shochat S et al. (1988) Localized neuroblastoma treated by surgery: a Pediatric Oncology Group Study. J Clin Oncol 6:1271–1279PubMedGoogle Scholar
  58. Notteghem P, Soler C, Dellatolas G et al. (2003) Neuropsychological outcome in long-term survivors of a childhood extracranial solid tumor who have undergone autologous bone marrow transplantation. Bone Marrow Transplant 31:599–606CrossRefPubMedGoogle Scholar
  59. Ogilvy-Stuart AL, Clark DJ, Wallace WHB et al. (1992) Endocrine deficit after fractionated total body irradiation. Arch Dis Child 67:1107–1110PubMedGoogle Scholar
  60. Olshan JS, Willi SM, Gruccio D et al. (1993) Growth hormone function and treatment following bone marrow transplant for neuroblastoma. Bone Marrow Transplant 12:381–385PubMedGoogle Scholar
  61. Parsons SK, Neault MW, Lehmann LE et al. (1998) Severe ototoxicity following carboplatin-containing conditioning regimen for autologous marrow transplantation for neuroblastoma. Bone Marrow Transplant 22:669–674CrossRefPubMedGoogle Scholar
  62. Pastore G, Antonelli R, Fine W et al. (1982) Late effects of treatment of cancer in infancy. Med Pediatr Oncol 10:369–375PubMedGoogle Scholar
  63. Pastore G, Zurlo MG, Acquaviva A et al. (1987) Health status of young children with cancer following discontinuation of therapy. Med Pediatr Oncol 15:1–6PubMedGoogle Scholar
  64. Paulino AC, Mayr NA, Simon JH et al. (2002) Locoregional control in infants with neuroblastoma: role of radiation therapy and late toxicity. Int J Radiat Oncol Biol Phys 52:1025–1031CrossRefPubMedGoogle Scholar
  65. Perez CA, Matthay K, Atkinson JB et al. (2000) Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a Children's Cancer Group Study. J Clin Oncol 18:18–26PubMedGoogle Scholar
  66. Phipps S, Brenner M, Heslop H et al. (1995) Psychological effects of bone marrow transplantation on children and adolescents: preliminary report of a longitudinal study. Bone Marrow Transplant 15:829–835PubMedGoogle Scholar
  67. Phipps S, Dunavant M, Srivastava DK et al. (2000) Cognitive and academic functioning in survivors of pediatric bone marrow transplantation. J Clin Oncol 18:1004–1011PubMedGoogle Scholar
  68. Picco P, Garaventa A, Claudiani F et al. (1993) Primary hypothyroidism and 131I-MIBG therapy in neuroblastoma [letter]. Lancet 342:57CrossRefGoogle Scholar
  69. Picco P, Garaventa A, Claudiani F et al. (1995) Primary hypothyroidism as a consequence of 131I-metaiodobenzylguanidine treatment for children with neuroblastoma. Cancer 76:1662–1664PubMedGoogle Scholar
  70. Piel J, Meyer D, Perlia CP et al. (1974) Effects of Cis-diamminedichloroplatinum (NSC-119875) on hearing function in man. Cancer Chemother Rep 58:871–875PubMedGoogle Scholar
  71. Plantaz D, Rubie H, Michon J et al. (1996) The treatment of neuroblastoma with intraspinal extension with chemotherapy followed by surgical removal of residual disease: a prospective study of 42 patients — results of the NBL 90 Study of the French Society of Pediatric Oncology. Cancer 78:311–319CrossRefPubMedGoogle Scholar
  72. Schell MJ, McHaney VA, Green AA et al. (1989) Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation. J Clin Oncol 7:754–760PubMedGoogle Scholar
  73. Schiavetti A, Varrasso G, Maurizi P et al. (2001) Two secondary leukemias among 15 children given oral etoposide. Med Pediatr Oncol 37:148–149CrossRefPubMedGoogle Scholar
  74. Shah NR, Miller DR, Steinherz PG et al. (1983) Acute monoblastic leukemia as a second malignant neoplasm in metastatic neuroblastoma. Am J Pediatr Hematol Oncol 5:309–313PubMedGoogle Scholar
  75. Shalet SM, Beardwell CG, Morris Jones PH et al. (1976) Ovarian failure following abdominal irradiation in childhood. Br J Cancer 33:655–658PubMedGoogle Scholar
  76. Simms S, Kazak AE, Gannon T et al. (1988) Neuropsychological outcome of children undergoing bone marrow transplantation. Bone Marrow Transplant 22:181–184CrossRefGoogle Scholar
  77. Simon T, Hero B, Dupuis W et al. (2002) The incidence of hearing impairment after successful treatment of neuroblastoma. Klin Padiatr 214:149–152 [in German]CrossRefPubMedGoogle Scholar
  78. Skinner R (2003) Chronic ifosfamide nephrotoxicity in children. Med Pediatr Oncol 41:190–197CrossRefPubMedGoogle Scholar
  79. Skinner R, Pearson ADJ, Amineddine HA et al. (1990) Ototoxicity of cisplatinum in children and adolescents. Br J Cancer 61:927–931PubMedGoogle Scholar
  80. Sklar C (1995a) Growth and endocrine disturbances after bone marrow transplantation in childhood. Acta Paediatr (Suppl) 411:57–62Google Scholar
  81. Sklar CA (1995b) Growth following therapy for childhood cancer. Cancer Invest 13:511–516PubMedGoogle Scholar
  82. Sklar C (1999) Reproductive physiology and treatment-related loss of sex hormone production. Med Pediatr Oncol 33:2–8CrossRefPubMedGoogle Scholar
  83. Sklar C, Whitton J, Mertens A et al. (2000) Abnormalities of the thyroid in survivors of Hodgkin's disease (HD): data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 85:3227–3232CrossRefPubMedGoogle Scholar
  84. Sonis AL, Tarbell N, Valachovic RW et al. (1990) Dentofacial development in long-term survivors of acute lymphoblastic leukemia: a comparison of three treatment modalities. Cancer 66:2645–2652PubMedGoogle Scholar
  85. Spilker B (ed) (1996) Quality of life and pharmacoeconomics in clinical trials, 2nd edn. Lippincott-Raven, PhiladelphiaGoogle Scholar
  86. Staquet MJ, Hays RD, Fayers PM (1998) Quality of life assessment in clinical trials: methods and practice. Oxford University Press, New YorkGoogle Scholar
  87. Steinherz LJ, Steinherz PG, Tan CTC et al. (1991) Cardiac toxicity 4 to 20 years after completing anthracycline therapy. J Am Med Assoc 266:1672–1677CrossRefGoogle Scholar
  88. Steinherz LJ, Steinherz PG, Tan C (1995) Cardiac failure and dysrhythmias 6–19 years after anthracycline therapy: a series of 15 patients. Med Pediatr Oncol 24:352–361PubMedGoogle Scholar
  89. Stillman RJ, Shinfeld JS, Schiff I et al. (1981) Ovarian failure in long-term survivors of childhood malignancy. Am J Obstet Gynecol 139:62–66PubMedGoogle Scholar
  90. Tabone MD, Terrier P, Pacquement H et al. (1999) Outcome of radiation-related osteosarcoma after treatment of childhood and a dolescent cancer: a study of 23 cases. J Clin Oncol 17:2789–2795PubMedGoogle Scholar
  91. Thibaud E, Rodriguez-Macias K, Trivin C et al. (1998) Ovarian function after bone marrow transplantation during childhood. Bone Marrow Transplant 21:287–290CrossRefPubMedGoogle Scholar
  92. Tucker MA, Morris Jones PH, Boice JD Jr et al. (1991) Therapeutic radiation at a young age is linked to secondary thyroid cancer. Cancer Res 51:2885–2888PubMedGoogle Scholar
  93. Van Santen HM, de Kraker J, van Eck BLF et al. (2002) High incidence of thyroid dysfunction despite prophylaxis with potassium iodide during 131I-metaiodobenzylguanidine treatment in children with neuroblastoma. Cancer 94:2081–2089CrossRefPubMedGoogle Scholar
  94. Van Santen HM, Vulsma T, Dijkgraaf MG et al. (2003) No damaging effect of chemotherapy in addition to radiotherapy on the thyroid axis in young adult survivors of childhood cancer. J Clin Endocrinol Metab 88:3657–3663CrossRefPubMedGoogle Scholar
  95. Wallace WH, Shalet SM, Crowne EC et al. (1989a) Ovarian failure following abdominal irradiation in childhood: natural history and prognosis. Clin Oncol (R Coll Radiol) 1:75–79Google Scholar
  96. Wallace WH, Shalet SM, Hendry JH et al. (1989b) Ovarian failure following abdominal irradiation in childhood: the radiosensitivity of the human ovocyte. Br J Radiol 62:995–998PubMedGoogle Scholar
  97. Weatherly RA, Owens JJ, Catlin FI et al. (1991) Cis-platinum ototoxicity in children. Laryngoscope 101:917–923PubMedGoogle Scholar
  98. Weiss B, Vora A, Huberty J et al. (2003) Secondary myelodysplatic syndrome and leukemia following 131I-metaiodobenzylguanidine therapy for relapsed neuroblastoma. J Pediatr Hematol Oncol 25:543–547CrossRefPubMedGoogle Scholar
  99. Willi SM, Cooke K, Goldwein J et al. (1992) Growth in children after bone marrow transplantation for advanced neuroblastoma compared with growth after transplantation for leukemia or aplastic anemia. J Pediatr 120:726–732PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • Caroline Laverdière
  • James Gurney
  • Charles A. Sklar

There are no affiliations available

Personalised recommendations